3 Stocks to Watch For: AK Steel Holding Corporation (AKS), Freeport-McMoRan Inc. (FCX), Pfizer Inc. (PFE)

AK Steel Holding Corporation (AKS) saw its value decrease by -10.44% as the stock dropped $-1.15 to finish the day at a closing price of $9.87. The stock was higher in trading and has fluctuated between $1.64-$11.39 per share for the past year. The shares, which traded within a range of $9.76 to $10.78 during the day, are up by 106.92% in the past three months and up by 78.16% over the past six months. It is currently trading -7.07% below its 20 day moving average and 7.9% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $9.43 a share over the next twelve months. The current relative strength index (RSI) reading is 46.36.The technical indicator lead us to believe there will be no major movement any time soon, hold.

AK Steel Holding Corporation, through its subsidiary, AK Steel Corporation, produces flat-rolled carbon, stainless and electrical steel, and tubular products in the United States and internationally. It produces flat-rolled value-added carbon steels, including coated, cold-rolled, and hot-rolled carbon steel products; and specialty stainless and electrical steels in sheet and strip forms. The company also produces carbon and stainless steel that is finished into welded steel tubing, which is used in the automotive, large truck, industrial, and construction markets; buys and sells steel and steel products, and other materials; and produces metallurgical coal from reserves in Pennsylvania. It sells its flat-rolled carbon steel products primarily to automotive manufacturers and to customers in the infrastructure and manufacturing markets, including electrical transmission, heating, ventilation and air conditioning equipment, and appliances; and coated, cold-rolled, and hot-rolled carbon steel products to distributors, service centers, and converters. The company sells its stainless steel products to manufacturers and their suppliers in the automotive industry; manufacturers of food handling, chemical processing, pollution control, and medical and health equipment; and distributors and service centers. It also sells electrical steel products to manufacturers of power transmission and distribution transformers, as well as for use in the manufacture of electrical motors and generators. AK Steel Holding Corporation was founded in 1993 and is headquartered in West Chester, Ohio.

Freeport-McMoRan Inc. (FCX) shares were down in last trading by -3.78% to $15.27. It experienced higher than average volume on day. The stock increased in value by almost 4.45% over the past week and fell -0.59% in the past month. It is currently trading 8.12% above its 50 day moving average and 28.55% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -7% decrease in value from its one year high of $16.42. The RSI indicator value of 57.44, lead us to believe that it is a hold for now.

Freeport-McMoRan Inc., a natural resource company, acquires, explores, and develops mineral assets, and oil and natural gas resources. The company explores for copper, gold, molybdenum, cobalt hydroxide, silver, and other metals, as well as oil and gas. It holds interests in various mines located in the Grasberg minerals district in Indonesia; Morenci, Bagdad, Safford, Sierrita, Miami, Chino, Tyrone, Henderson, and Climax in North America; Cerro Verde and El Abra in South America; and the Tenke Fungurume minerals district in the Democratic Republic of Congo, Africa. The company’s oil and gas operations include oil production facilities in the Deepwater Gulf of Mexico; oil production facilities onshore and offshore in California; onshore natural gas resources in the Haynesville shale in Louisiana; natural gas production from the Madden area in central Wyoming; and a position in the Inboard Lower Tertiary/Cretaceous natural gas trend onshore located in South Louisiana. As of December 31, 2015, its consolidated recoverable proven and probable mineral reserves included 99.5 billion pounds of copper, 27.1 million ounces of gold, 3.05 billion pounds of molybdenum, 271.2 million ounces of silver, and 0.87 billion pounds of cobalt; and its estimated proved oil and natural gas reserves totaled 252 million barrels of oil equivalents. The company was formerly known as Freeport-McMoRan Copper & Gold Inc. and changed its name to Freeport-McMoRan Inc. in July 2014. Freeport-McMoRan Inc. was founded in 1987 and is headquartered in Phoenix, Arizona.

Pfizer Inc. (PFE) traded within a range of $32.3 to $32.62 after opening the day at $32.53. The company has seen its stock increase in value by 0.37% so far this year. The stock was down close to -0.7% on active volume in last trading session and closed at $32.6 per share. After the recent fall, the stock is currently holding -11.21% below its 52 week high of $37.39 and 18.57% above its 12-month low of $28.25. The shares are down by over -0.44% in the last three months, and the RSI indicator value of 47.12 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. It also has a collaboration with AbCellera Biologics Inc. to discover therapeutic antibodies against undisclosed membrane protein targets. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

 

Stocks Buzz: Pfizer Inc. (PFE), Microsoft Corporation (MSFT), Frontier Communications Corporation (FTR)

Pfizer Inc. (PFE) continued its downward trend with the stock declining -0.09% or $-0.03 to close the day at $33.44 on light trading volume of 19.37M shares, compared to its three month average trading volume of 26.17M. The New York New York 10017 based company has been outperforming the drug manufacturers – major group over the past 52 weeks, with the stock gaining 11.7%, compared to the industry which has advanced 8.91% over the same period. With RSI of 63.69, the stock should still continue to rise and get closer to its one year target estimate of $37.65, making it a hold for now.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. It also has a collaboration with AbCellera Biologics Inc. to discover therapeutic antibodies against undisclosed membrane protein targets. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Microsoft Corporation (MSFT) retreated with the stock falling -0.03% or $-0.02 to close at $62.62 on light trading volume of 18.59M compared its three months average trading volume of 27.66M. The Redmond Washington 98052 based company operating under the Business Software & Services industry has been trending up for the last 52 weeks, with the shares price now 23.02% up for the period and up by 0.77% so far this year. With price target of $65.5 and a 33.51% rebound from 52-week low, Microsoft Corporation has plenty of upside potential, making it a hold with a view buy.

Microsoft Corporation, a technology company, develops, licenses, and supports software products, services, and devices worldwide. The company’s Productivity and Business Processes segment offers Office 365 commercial products and services for businesses, including Office, Exchange, SharePoint, and Skype, as well as related Client Access Licenses (CALs); Office 365 consumer services, such as Skype, Outlook.com, and OneDrive; Dynamics business solutions, such as financial management, customer relationship management, supply chain management, and analytics applications for small and mid-size businesses, large organizations, and divisions of enterprises; and LinkedIn online professional network. Its Intelligent Cloud segment licenses server products and cloud services, such as SQL Server, Windows Server, Visual Studio, System Center, and related CALs, as well as Azure, a cloud platform with computing, networking, storage, database, and management services; and enterprise services, such as Premier Support and Microsoft Consulting that assist in developing, deploying, and managing Microsoft server and desktop solutions, as well as provide training and certification to developers and IT professionals on Microsoft products. The company’s More Personal Computing segment comprises Windows OEM, volume, and other non-volume licensing of the Windows operating system, as well as patent licensing, Windows Embedded, MSN display advertising, and Windows Phone licensing system; devices, including Microsoft Surface, phones, and PC accessories; and search advertising, including Bing and Bing Ads. This segment also provides gaming platforms, including Xbox hardware, Xbox Live, video games, and third-party video games. The company markets and distributes its products through original equipment manufacturers (OEM), distributors, and resellers, as well as through online and Microsoft retail stores. Microsoft Corporation was founded in 1975 and is headquartered in Redmond, Washington.

Frontier Communications Corporation (FTR) continued its downward trend with the stock declining -1.36% or $-0.05 to close the day at $3.63 on lower than average trading volume of 18.37M shares, compared to its three month average trading volume of 22.14M. The Norwalk Connecticut 06851 based company has been outperforming the telecom services – domestic companies by -9.8618% for last three months and its recent losses have trimmed gains to 7.4% YTD, versus the telecom services – domestic industry which is down -1.02% for the same period. The RSI of 59.05 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Frontier Communications Corporation provides regulated and unregulated voice, data, and video services to residential, business, and wholesale customers in the United States. The company offers residential services, such as fiber-to-the-home and fiber-to-the-node broadband, as well as traditional copper-based broadband products; and commercial services, including Ethernet, dedicated Internet, multiprotocol label switching, time division multiplexing, data transport services, and optical transport services. It also provides Frontier Secure suite of products for computer security, cloud backup and sharing, identity protection, equipment insurance, and technical support; unified messaging services comprising call forwarding, conference calling, caller identification, voicemail, and call waiting services; long distance network services; and packages of communications services. In addition, the company offers switched access services that facilitate other carriers to use the company’s facilities to originate and terminate their local and long distance voice traffic; satellite TV video services; and a range of third-party communications equipment to small, medium, and enterprise business customers. As of December 31, 2015, it had approximately 3,124,200 residential customers; approximately 289,200 business customers; and 2,462,100 broadband subscribers. The company also operates a retail store in Southern California. The company was formerly known as Citizens Communications Company and changed its name to Frontier Communications Corporation in July 2008. Frontier Communications Corporation was founded in 1927 and is based in Norwalk, Connecticut.

 

Stocks in Review: General Electric (GE), Pfizer (PFE), Micron Technology (MU)

Micron Technology, Inc. (MU) opening the day at $21.94. The company has seen its stock increase in value by 1.92% so far this year. The stock was up close to 1.36% on light volume in last trading session and closed at $22.34 per share. After the recent gain, the stock is currently holding -5.5% below its 52 week high of $23.64 and 139.96% above its 12-month low of $9.31. The shares are up by over 26.86% in the last three months, and the RSI indicator value of 63.25 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Micron Technology, Inc. provides semiconductor systems worldwide. The company operates through four segments: Compute and Networking Business Unit, Storage Business Unit, Mobile Business Unit, and Embedded Business Unit. It offers DDR3 and DDR4 DRAM products for computers, servers, networking devices, communications equipment, consumer electronics, automotive, and industrial applications; mobile low-power DRAM products for smartphones, tablets, automotive, laptop computers, and other mobile consumer device applications; DDR2 and DDR DRAM, GDDR5 and GDDR5X DRAM, SDRAM, and RLDRAM products for networking devices, servers, consumer electronics, communications equipment, computer peripherals, automotive and industrial applications, and computer memory upgrades; and hybrid memory cube semiconductor memory devices for use in networking and computing applications. The company also provides NAND Flash products, which are electrically re-writeable, non-volatile semiconductor memory devices; client solid-state drives (SSDs) for notebooks, desktops, workstations, and other consumer applications; enterprise SSDs for server and storage applications; managed multi-chip package products; digital media products, including flash memory cards and JumpDrive products under the Lexar brand name. In addition, it manufactures products that are sold under other brand names; and resells flash memory products that are purchased from other NAND Flash suppliers. Further, the company provides 3D XPoint memory products; and NOR Flash, which are electrically re-writeable and semiconductor memory devices for automotive, industrial, connected home, and consumer applications. It markets its products to original equipment manufacturers and retailers through its internal sales force, independent sales representatives, and distributors; and through a Web-based customer direct sales channel, and channel and distribution partners. The company was founded in 1978 and is headquartered in Boise, Idaho.

General Electric Company (GE) failed to extend gains with the stock declining -0.47% or $-0.15 to close the day at $31.46 on light trading volume of 21.17M shares, compared to its three month average trading volume of 32.43M. The Boston Massachusetts 02210 based company has been outperforming the diversified machinery group over the past 52 weeks, with the stock gaining 14.04%, compared to the industry which has advanced 26% over the same period. With RSI of 54.64, the stock should still continue to rise and get closer to its one year target estimate of $34, making it a hold for now.

General Electric Company (GE) operates as an infrastructure and financial services company worldwide. Its Power segment offers gas and steam power systems; maintenance, service, and upgrade solutions; distributed power gas engines; water treatment, wastewater treatment, and process system solutions; and nuclear reactors, fuels, and support services. The company’s Renewable Energy segment offers wind turbine platforms, and hardware and software; offshore wind turbines; and solutions, products, and services to hydropower industry. Its Oil and Gas segment offers turbomachinery solutions; surface and subsea drilling and production systems, and equipment for floating production platforms; measurement and control products; and compressors, pumps, valves, and natural gas solutions. The company’s Energy Management segment offers industrial and grid solutions, and power conversion systems. Its Aviation segment designs and produces commercial and military aircraft engines, integrated digital components, electric power, and mechanical aircraft systems; and offers aftermarket services. The company’s Healthcare segment offers diagnostic imaging and clinical systems; products for drug discovery, biopharmaceutical manufacturing, and cellular technologies; and healthcare information technology products. Its Transportation segment offers freight and passenger locomotives, parts, wreck repair, software-enabled solutions, mining equipment and services, marine diesel engines, and stationary power diesel engines and motors, as well as overhaul, repair, and upgrade services. GE’s Appliances & Lighting segment sells and services home appliances; and manufactures, sources, and sells lighting solutions. Its Capital segment offers commercial lending and leasing, factoring, energy financial, and aircraft financing and leasing services. GE also designs powder bed-based laser additive manufacturing machines. The company was founded in 1892 and is headquartered in Fairfield, Connecticut.

Pfizer Inc. (PFE) dropped $-0.01 to close the day at a new closing price of $33.47, a -0.03% decrease in value from its previous closing price that moved the stock 21.73% above its 52 week low of $28.25. A total of 20.43M shares exchanged hands during the day compared with its three month average trading volume of 26.08M. The stock, which fluctuated between $33.38 and $33.67 during the day, currently situated -8.84% below its 52 week high. The stock is up by 7.31% in the past one month and up by 0.73% over the past three months. With a one year target estimate of $37.65 and RSI of 67.65, the stock still has upside potential, making it a hold for now.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. It also has a collaboration with AbCellera Biologics Inc. to discover therapeutic antibodies against undisclosed membrane protein targets. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

 

Stocks in the Spotlight: Micron Technology, Inc. (MU), Pfizer Inc. (PFE), Rennova Health, Inc. (RNVA)

Micron Technology, Inc. (MU) had a light trading with around 17.77M shares changing hands compared to its three month average trading volume of 25.63M. The stock traded between $21.98 and $22.28 before closing at the price of $22.04 with -0.32% change on the day. The Boise Idaho 83716 based company is currently trading 136.73% above its 52 week low of $9.31 and -6.77% below its 52 week high of $23.64. Both the RSI indicator and target price of 60.83 and $26.58 respectively, lead us to believe that it should be put on hold over the coming weeks.

Micron Technology, Inc. provides semiconductor systems worldwide. The company operates through four segments: Compute and Networking Business Unit, Storage Business Unit, Mobile Business Unit, and Embedded Business Unit. It offers DDR3 and DDR4 DRAM products for computers, servers, networking devices, communications equipment, consumer electronics, automotive, and industrial applications; mobile low-power DRAM products for smartphones, tablets, automotive, laptop computers, and other mobile consumer device applications; DDR2 and DDR DRAM, GDDR5 and GDDR5X DRAM, SDRAM, and RLDRAM products for networking devices, servers, consumer electronics, communications equipment, computer peripherals, automotive and industrial applications, and computer memory upgrades; and hybrid memory cube semiconductor memory devices for use in networking and computing applications. The company also provides NAND Flash products, which are electrically re-writeable, non-volatile semiconductor memory devices; client solid-state drives (SSDs) for notebooks, desktops, workstations, and other consumer applications; enterprise SSDs for server and storage applications; managed multi-chip package products; digital media products, including flash memory cards and JumpDrive products under the Lexar brand name. In addition, it manufactures products that are sold under other brand names; and resells flash memory products that are purchased from other NAND Flash suppliers. Further, the company provides 3D XPoint memory products; and NOR Flash, which are electrically re-writeable and semiconductor memory devices for automotive, industrial, connected home, and consumer applications. It markets its products to original equipment manufacturers and retailers through its internal sales force, independent sales representatives, and distributors; and through a Web-based customer direct sales channel, and channel and distribution partners. The company was founded in 1978 and is headquartered in Boise, Idaho.

Pfizer Inc. (PFE) failed to extend gains with the stock declining -0.39% or $-0.13 to close the day at $33.48 on light trading volume of 17.41M shares, compared to its three month average trading volume of 26.07M. The New York New York 10017 based company has been outperforming the drug manufacturers – major group over the past 52 weeks, with the stock gaining 10.66%, compared to the industry which has advanced 6.09% over the same period. With RSI of 67.75, the stock should still continue to rise and get closer to its one year target estimate of $37.65, making it a hold for now.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. It also has a collaboration with AbCellera Biologics Inc. to discover therapeutic antibodies against undisclosed membrane protein targets. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Rennova Health, Inc. (RNVA) shares were up in last trading by 3.15% to $0.09. It experienced higher than average volume on day. The stock increased in value by almost 6.63% over the past week and fell -4.32% in the past month. It is currently trading -21.44% below its 50 day moving average and -76.28% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -92.75% decrease in value from its one year high of $1.16. The RSI indicator value of 44.12, lead us to believe that it is a hold for now.

Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers in the United States. It offers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management solutions, as well as intends to provide financial services in the form of loans to physician practices. The company provides toxicology, clinical pharmacogenetics, and esoteric testing services; develops Web-based system to place lab orders, track samples, and view test reports in real time; Web-enabled laboratory information management solutions; Medical Mime, which offers an electronic health record for substance abuse and behavioral health providers; and CollabRx that enhances cancer diagnoses and treatment through actionable data analytics and reporting for oncologists and their patients. Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida.

 

Stocks in Review: Apple Inc. (AAPL), Pfizer Inc. (PFE), Fitbit, Inc. (FIT)

Apple Inc. (AAPL) traded within a range of $115.81 to $116.86 after opening the day at $115.92. The company has seen its stock increase in value by 0.68% so far this year. The stock was up close to 0.51% on light volume in last trading session and closed at $116.61 per share. After the recent gain, the stock is currently holding -1.25% below its 52 week high of $118.69 and 31.71% above its 12-month low of $89.47. The shares are up by over 3.68% in the last three months, and the RSI indicator value of 62.72 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Apple Inc. designs, manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players to consumers, small and mid-sized businesses, and education, enterprise, and government customers worldwide. The company also sells related software, services, accessories, networking solutions, and third-party digital content and applications. It offers iPhone, a line of smartphones; iPad, a line of multi-purpose tablets; and Mac, a line of desktop and portable personal computers. The company also provides iLife, a consumer-oriented digital lifestyle software application suite; iWork, an integrated productivity suite that helps users create, present, and publish documents, presentations, and spreadsheets; and other application software, such as Final Cut Pro, Logic Pro X, and FileMaker Pro. In addition, it offers Apple TV that connects to consumers’ TV and enables them to access digital content directly for streaming high definition video, playing music and games, and viewing photos; Apple Watch, a personal electronic device; and iPod, a line of portable digital music and media players. Further, the company sells Apple-branded and third-party Mac-compatible, and iOS-compatible accessories, such as headphones, displays, storage devices, Beats products, and other connectivity and computing products and supplies. Additionally, it offers iCloud, a cloud service; AppleCare that offers support options for its customers; and Apple Pay, a mobile payment service. The company sells and delivers digital content and applications through the iTunes Store, App Store, Mac App Store, TV App Store, iBooks Store, and Apple Music. It also sells its products through its retail and online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers, and value-added resellers. Apple Inc. was founded in 1977 and is headquartered in Cupertino, California.

Pfizer Inc. (PFE) continued its upward trend with the stock climbing 0.96% or $0.32 to close the day at $33.61 on light trading volume of 19.98M shares, compared to its three month average trading volume of 25.98M. The New York New York 10017 based company has been outperforming the drug manufacturers – major group over the past 52 weeks, with the stock gaining 10.35%, compared to the industry which has advanced 4.89% over the same period. With RSI of 70.88, the stock should still continue to rise and get closer to its one year target estimate of $37.65, making it a hold for now.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute to conduct clinical trials to evaluate investigational immunotherapy agents. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Fitbit, Inc. (FIT) dropped $-0.26 to close the day at a new closing price of $7.86, a -3.2% decrease in value from its previous closing price that moved the stock 9.17% above its 52 week low of $7.2. A total of 19.95M shares exchanged hands during the day compared with its three month average trading volume of 10.84M. The stock, which fluctuated between $7.84 and $8.23 during the day, currently situated -74.61% below its 52 week high. The stock is down by -2.12% in the past one month and down by -46.78% over the past three months. With a one year target estimate of $10.75 and RSI of 50.7, the stock still has upside potential, making it a hold for now.

Fitbit, Inc. provides wearable health and fitness tracking devices. It offers various products, including Fitbit Zip, an entry-level wireless tracker that allows users to track daily activity statistics, such as steps, distance, calories burned, and active minutes; Fitbit One, a clippable wireless tracker, which tracks floors climbed and sleep, as well as daily steps, distance, calories burned, and active minutes; Fitbit Flex, a wristband-style tracker that tracks steps, distance, calories burned, active minutes, and sleep; and Fitbit Charge, an activity and sleep wristband, which tracks steps, distance, calories burned, active minutes, floors climbed, and sleep. The company also provides Fitbit Alta, a customizable wristband that offers call, text, and calendar notifications when paired with the user’s phone and SmartTrack automatic exercise recognition; and Fitbit Charge HR, a wireless heart rate and activity wristband. In addition, it offers Fitbit Blaze, a smart fitness watch that provides multi-sport functionality, tracks outdoor cycling activity, and provides run cues; Fitbit Surge, a fitness watch that features a GPS watch, heart rate tracker, activity tracker, and smartwatch; Aria, a Wi-Fi connected scale that tracks weight, body fat percentage, and body mass index; and Fitbit accessories that include bands and frames for Fitbit Blaze, bands for Fitbit Alta, colored bands for Fitbit Flex, colored clips for Fitbit One and Fitbit Zip, device charging cables, wireless sync dongles, band clasps, sleep bands, and Fitbit apparel. The company offers its products through consumer electronics and specialty retailers, e-Commerce retailers, sporting goods and outdoors retailers, and wireless carriers; and corporate wellness channels, as well as directly worldwide. The company was formerly known as Healthy Metrics Research, Inc. and changed its name to Fitbit, Inc. in October 2007. Fitbit, Inc. was founded in 2007 and is headquartered in San Francisco, California.

 

Stocks in Review: Verizon Communications Inc. (VZ), Cisco Systems, Inc. (CSCO), Pfizer Inc. (PFE)

Verizon Communications Inc. (VZ) traded within a range of $53.73 to $54.67 after opening the day at $53.96. The company has seen its stock increase in value by 2.25% so far this year. The stock was up close to 2.25% on active volume in last trading session and closed at $54.58 per share. After the recent gain, the stock is currently holding -2.09% below its 52 week high of $56.95 and 28.68% above its 12-month low of $43.79. The shares are up by over 6.4% in the last three months, and the RSI indicator value of 74.44 is bearish. The technical indicator is offering a warning sign that the stock can’t keep current pace going.

Verizon Communications Inc., through its subsidiaries, provides communications, information, and entertainment products and services to consumers, businesses, and governmental agencies worldwide. Its Wireless segment offers wireless voice and data services; messaging services; wireless Internet access services on notebook computers and tablets; multimedia access services; business-focused services; location-based services; global data services; home phone connect services; high-speed Internet service; and network access and value added services to support wireless connections for the Internet of Things (IoT). This segment also provides IoT services that support devices used in health monitoring, education, manufacturing, utilities, distribution, and consumer products markets, as well as offers wireless devices, including smartphones and basic phones, tablets, and other Internet access devices. As of December 31, 2015, it had 112.1 million retail connections. The company’s Wireline segment provides high-speed Internet, Fios Internet, and Fios video services; voice services, such as local exchange, regional and long distance calling, and voice messaging services, as well as VoIP services; network products and solutions comprising private Internet protocol (IP), public Internet, Ethernet, and optical networking services; IT infrastructure services, including collocation and managed hosting; cloud services, such as computing, storage, backup, recovery, and application platforms; and business communications services. This segment also offers IoT services; data security services; voice and data services; and data, voice, local dial tone, and broadband services primarily to local, long distance, and other carriers. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was founded in 1983 and is based in New York, New York.

Cisco Systems, Inc. (CSCO) managed to rebound with the stock climbing 1.06% or $0.32 to close the day at $30.54 on active trading volume of 22.29M shares, compared to its three month average trading volume of 21.77M. The San Jose California 95134 based company has been outperforming the networking & communication devices group over the past 52 weeks, with the stock gaining 18.73%, compared to the industry which has advanced 15.25% over the same period. With RSI of 54.09, the stock should still continue to rise and get closer to its one year target estimate of $33.11, making it a hold for now.

Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol (IP) based networking and other products related to the communications and information technology industry worldwide. It provides switching products, including fixed-configuration and modular switches, and storage products that provide connectivity to end users, workstations, IP phones, wireless access points, and servers; and next-generation network routing products that interconnect public and private wireline and mobile networks for mobile, data, voice, and video applications. The company also offers service provider video infrastructure, including set-top boxes, cable/telecommunications access products, and cable modems; and video software and solutions. In addition, it provides collaboration products comprising unified communications products, conferencing products, collaboration endpoints, and business messaging products; data center products, such as blade and rack servers, modular servers, fabric interconnects, software, and server access virtualization solutions; security products, including network and data center security, advanced threat protection, Web and email security, access and policy, unified threat management, and advisory, integration, and managed services; and other products, such as emerging technologies and other networking products. Further, the company offers wireless products consisting of wireless access points; network managed services; and standalone, switch-converged, and cloud managed solutions. Additionally, it provides technical support services and advanced services. The company serves businesses of various sizes, public institutions, governments, and communications service providers. Cisco Systems, Inc. sells its products directly, as well as through channel partners, such as systems integrators, service providers, other resellers, and distributors. The company was founded in 1984 and is headquartered in San Jose, California.

Pfizer Inc. (PFE) gained $0.52 to close the day at a new closing price of $33, a 1.6% increase in value from its previous closing price that moved the stock 20.03% above its 52 week low of $28.25. A total of 22.13M shares exchanged hands during the day compared with its three month average trading volume of 25.9M. The stock, which fluctuated between $32.59 and $33 during the day, currently situated -10.12% below its 52 week high. The stock is up by 4.9% in the past one month and down by -1.04% over the past three months. With a one year target estimate of $37.65 and RSI of 63.67, the stock still has upside potential, making it a hold for now.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute to conduct clinical trials to evaluate investigational immunotherapy agents. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

 

3 Notable Runners: Facebook (FB), Cempra (CEMP), Pfizer (PFE)

Cempra, Inc. (CEMP) managed to rebound with the stock climbing 7.69% or $0.2 to close the day at $2.8 on lower than average trading volume of 19.55M shares, compared to its three month average trading volume of 2.53M. The Chapel Hill North Carolina 27517 based company has been underperforming the biotechnology companies by -88.2606% for last three months and its recent losses have pulled the stock down -91.01% YTD, versus the biotechnology industry which is down -0.87% for the same period. The RSI of 19.19 indicates the stock is oversold at the current levels, buy for now.

Cempra, Inc., a clinical-stage pharmaceutical company, focuses on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases in North America. Its lead product candidates include solithromycin (CEM-101), which is in Phase III clinical trials for the treatment of community acquired bacterial pneumonia, as well as for uncomplicated bacterial urethritis; and Taksta, an antibiotic that has completed Phase II clinical trials for refractory bone and joint infections. The company also produces novel macrolides for non-antibiotic uses, such as the treatment of chronic inflammatory diseases, endocrine diseases, and gastric motility disorders. It has collaborative research and development and license agreement with Optimer Pharmaceuticals, Inc. The company was formerly known as Cempra Holdings, LLC and changed its name to Cempra, Inc. in February 2012. Cempra, Inc. was founded in 2005 and is headquartered in Chapel Hill, North Carolina.

Pfizer Inc. (PFE) had a light trading with around 18.87M shares changing hands compared to its three month average trading volume of 26.06M. The stock traded between $32.31 and $32.6 before closing at the price of $32.48 with -0.03% change on the day. The New York New York 10017 based company is currently trading 18.13% above its 52 week low of $28.25 and -11.54% below its 52 week high of $37.39. Both the RSI indicator and target price of 56.31 and $37.65 respectively, lead us to believe that it should be put on hold over the coming weeks.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute to conduct clinical trials to evaluate investigational immunotherapy agents. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Facebook, Inc. (FB) traded within a range of $114.77 to $116.83 after opening the day at $116.6. The company has seen its stock increase in value by 9.93% so far this year. The stock was down close to -1.12% on light volume in last trading session and closed at $115.05 per share. After the recent fall, the stock is currently holding -13.82% below its 52 week high of $133.5 and 28.73% above its 12-month low of $89.37. The shares are down by over -10.31% in the last three months, and the RSI indicator value of 33.6 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Facebook, Inc. operates as a mobile application and Website that enables people to connect, share, discover, and communicate each other on mobile devices and personal computers worldwide. Its solutions also include Instagram, a mobile application that enables people to take photos or videos, customize them with filter effects, and share them with friends and followers in a photo feed or send them directly to friends; Messenger, a messaging application for mobile and Web on various platforms and devices, which enable people to reach others instantly, as well as enable businesses to engage with customers; and WhatsApp Messenger, a mobile messaging application. The company also develops Oculus virtual reality technology and content platform, which allow people to enter an immersive and interactive environment to play games, consume content, and connect with others. As of December 31, 2015, it had 1.04 billion daily active users (DAUs) and 934 million DAUs who accessed Facebook from a mobile device. The company has a partnership with the Federation of Indian Chambers of Commerce and Industry to augment the Millennium Alliance initiative, as well as support and expand the development of the social enterprise sector in India. Facebook, Inc. was founded in 2004 and is headquartered in Menlo Park, California.

 

Stocks in the Spotlight: Pfizer Inc. (PFE), Sprint Corporation (S), Regions Financial Corporation (RF)

Pfizer Inc. (PFE) had a light trading with around 14.07M shares changing hands compared to its three month average trading volume of 26.23M. The stock traded between $32.37 and $32.62 before closing at the price of $32.49 with 0.43% change on the day. The New York New York 10017 based company is currently trading 18.17% above its 52 week low of $28.25 and -11.51% below its 52 week high of $37.39. Both the RSI indicator and target price of 55.12 and $37.65 respectively, lead us to believe that it should be put on hold over the coming weeks.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute to conduct clinical trials to evaluate investigational immunotherapy agents. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Sprint Corporation (S) continued its upward trend with the stock climbing 1.03% or $0.09 to close the day at $8.81 on light trading volume of 13.92M shares, compared to its three month average trading volume of 19.35M. The Overland Park Kansas 66251 based company has been outperforming the wireless communications group over the past 52 weeks, with the stock gaining 142.7%, compared to the industry which has advanced 5.2% over the same period. With RSI of 70.58, the stock should still continue to rise and get closer to its one year target estimate of $7.28, making it a hold for now.

Sprint Corporation, through its subsidiaries, provides various wireless and wireline communications products and services to consumers, businesses, government subscribers, and resellers in the United States, Puerto Rico, and the U.S. Virgin Islands. The company operates in two segments, Wireless and Wireline. The Wireless segment offers wireless data communication services, including mobile productivity applications, such as Internet access, messaging, and email services; wireless photo and video offerings; location-based capabilities comprising asset and fleet management, dispatch services, and navigation tools; and mobile entertainment applications. It also provides wireless voice communications services that include local and long-distance wireless voice services, as well as voicemail, call waiting, three-way calling, caller identification, directory assistance, and call forwarding services. In addition, this segment offers voice and data services internationally through roaming arrangements; and customized wireless services to large companies and government agencies, as well as sells wireless devices, broadband devices, connected devices, and accessories to agents and other third-party distributors. The Wireline segment provides wireline voice and data communications, including domestic and international data communications using various protocols, such as multiprotocol label switching technologies, Internet protocol (IP), managed network services, Voice over IP, session initiated protocol, and traditional voice services to other communications companies, and targeted business and consumer subscribers, as well as for cable multiple system operators. Sprint Corporation offers its services under the Sprint, Boost Mobile, Virgin Mobile, and Assurance Wireless brands. The company was founded in 1899 and is headquartered in Overland Park, Kansas. Sprint Corporation is a subsidiary of SoftBank Group Corp.

Regions Financial Corporation (RF) shares were down in last trading by -1.8% to $14.17. It experienced lighter than average volume on day. The stock decreased in value by almost -2.48% over the past week and grew 8% in the past month. It is currently trading 11.36% above its 50 day moving average and 41.8% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -3.8% decrease in value from its one year high of $14.73. The RSI indicator value of 58.05, lead us to believe that it is a hold for now.

 

Stocks in the Spotlight: Sirius XM Holdings Inc. (SIRI), Facebook, Inc. (FB), Pfizer Inc. (PFE)

Sirius XM Holdings Inc. (SIRI) had a light trading with around 11.11M shares changing hands compared to its three month average trading volume of 40.43M. The New York New York 10020 based company is currently trading 37.41% above its 52 week low of $3.29 and -3.01% below its 52 week high of $4.65. Both the RSI indicator and target price of 53.19 and $4.89 respectively, lead us to believe that it should be put on hold over the coming weeks.

Sirius XM Holdings Inc. provides satellite radio services in the United States. The company broadcasts music plus sports, entertainment, comedy, talk, news, traffic, and weather programs, including various music genres ranging from rock, pop and hip-hop to country, dance, jazz, Latin, and classical; live play-by-play sports from principal leagues and colleges; multitude of talk and entertainment channels for various audiences; national, international, and financial news; and local traffic and weather reports for 21 metropolitan markets. It also streams music and non-music channels over the Internet; and offer applications to allow consumers to access its Internet radio service on smartphones and tablet computers. In addition, the company distributes satellite radios through the sale and lease of new vehicles; and acquires subscribers through the sale and lease of previously owned vehicles with factory-installed satellite radios. Its satellite radio systems include satellites, terrestrial repeaters, and other satellite facilities; studios; and radios. Further, the company provides satellite television services, which offer music channels on the DISH NETWORK satellite television service as a programming package; Travel Link, a suite of data services that include graphical weather, fuel prices, sports schedule and scores, and movie listings; real-time traffic services; and real-time weather services. Additionally, it offers location-based services through two-way wireless connectivity, including safety, security, convenience, maintenance and data services, remote vehicles diagnostics, stolen or parked vehicle locator services, and monitoring of vehicle emission systems. The company also sells satellite and Internet radios directly to consumers through its Website, as well as through national and regional retailers. The company was founded in 1990 and is headquartered in New York, New York. Sirius XM Holdings Inc. operates as a subsidiary of Liberty Media Corporation.

Facebook, Inc. (FB) continued its downward trend with the stock declining -0.11% or $-0.13 to close the day at $117.27 on light trading volume of 10.88M shares, compared to its three month average trading volume of 21.9M. The Menlo Park California 94025 based company has been outperforming the internet information providers group over the past 52 weeks, with the stock gaining 11.66%, compared to the industry which has advanced 4.31% over the same period. With RSI of 39.04, the stock should still continue to rise and get closer to its one year target estimate of $155.56, making it a hold for now.

Facebook, Inc. operates as a mobile application and Website that enables people to connect, share, discover, and communicate each other on mobile devices and personal computers worldwide. Its solutions also include Instagram, a mobile application that enables people to take photos or videos, customize them with filter effects, and share them with friends and followers in a photo feed or send them directly to friends; Messenger, a messaging application for mobile and Web on various platforms and devices, which enable people to reach others instantly, as well as enable businesses to engage with customers; and WhatsApp Messenger, a mobile messaging application. The company also develops Oculus virtual reality technology and content platform, which allow people to enter an immersive and interactive environment to play games, consume content, and connect with others. As of December 31, 2015, it had 1.04 billion daily active users (DAUs) and 934 million DAUs who accessed Facebook from a mobile device. The company has a partnership with the Federation of Indian Chambers of Commerce and Industry to augment the Millennium Alliance initiative, as well as support and expand the development of the social enterprise sector in India. Facebook, Inc. was founded in 2004 and is headquartered in Menlo Park, California.

Pfizer Inc. (PFE) shares were up in last trading by 0.43% to $32.48. It experienced lighter than average volume on day. The stock decreased in value by almost -1.1% over the past week and grew 3.37% in the past month. It is currently trading 2.08% above its 50 day moving average and -1.52% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -11.54% decrease in value from its one year high of $37.39. The RSI indicator value of 54.16, lead us to believe that it is a hold for now.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute to conduct clinical trials to evaluate investigational immunotherapy agents. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

 

Three Movers to Watch for: Real Goods Solar, Inc. (RGSE), Rite Aid Corporation (RAD), Pfizer Inc. (PFE)

Real Goods Solar, Inc. (RGSE) retreated with the stock falling -22.92% or $-0.08 to close at $0.27 on light trading volume of 18.98M compared its three months average trading volume of 4.28M. The Louisville Colorado 80027 based company operating under the General Building Materials industry has been trending down for the last 52 weeks, with the shares price now -98.23% down for the period and down by -97.86% so far this year. With price target of $2.66 and a 49.83% rebound from 52-week low, Real Goods Solar, Inc. has plenty of upside potential, making it a hold with a view buy.

Real Goods Solar, Inc. operates as a residential and commercial solar energy engineering, procurement, and construction company in the United States. It operates in three segments: Residential, Sunetric, and Other. The company offers solar energy services, including design, procurement, permitting, build-out, grid connection, financing referrals, and warranty and customer satisfaction. It installs residential solar energy systems up to 15 kilowatts (kW) in size; and small commercial solar energy systems up to 500 kW in size for various industries, such as retail, manufacturing, service, and municipal services. The company markets its products and services through an outside sales team, e-sales, and inside sales, customer referral programs, and alliances and channel partnerships, as well as online. Real Goods Solar, Inc. was founded in 1978 and is headquartered in Louisville, Colorado.

Rite Aid Corporation (RAD) dropped $-0.03 to close the day at a new closing price of $8.44, a -0.35% decrease in value from its previous closing price that moved the stock 33.33% above its 52 week low of $6.33. A total of 18.71M shares exchanged hands during the day compared with its three month average trading volume of 17.63M. The stock, which fluctuated between $8.35 and $8.47 during the day, currently situated -2.88% below its 52 week high. The stock is up by 10.33% in the past one month and up by 4.33% over the past three months. With a one year target estimate of $8.69 and RSI of 62.09, the stock still has upside potential, making it a hold for now.

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy Segment sells prescription drugs; and a range of other merchandises, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services, including screenings, medical tests, immunizations, and basic physical exams. In addition, this segment provides health coaching, shared decision making tools, and health care analytics, including health coaching for medical decisions, chronic conditions, and wellness; population analytic solutions; and consulting services. The Pharmacy Services Segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. It also offers integrated mail-order and specialty pharmacy services; and performs prescription adjudication services for other PBMs. Rite Aid Corporation has a strategic alliance with GNC. As of February 27, 2016, the company operated approximately 4,561 stores in 31 states of the United States and in the District of Columbia. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

Pfizer Inc. (PFE) shares were down in last trading by -0.19% to $32.34. It experienced lighter than average volume on day. The stock decreased in value by almost -1.25% over the past week and grew 3.22% in the past month. It is currently trading 1.62% above its 50 day moving average and -1.89% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -11.92% decrease in value from its one year high of $37.39. The RSI indicator value of 52.6, lead us to believe that it is a hold for now.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute to conduct clinical trials to evaluate investigational immunotherapy agents. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.